Skip to main content
. Author manuscript; available in PMC: 2010 May 6.
Published in final edited form as: Eye (Lond). 2009 Apr 17;23(5):1019–1027. doi: 10.1038/eye.2009.53

Table 1.

Genetic mutation sequence in the studied patients

Patient No./Age, y XLRS1 genetic
mutation
OD/OS VA
logMAR
OD/OS Color
vision on
Ishihara test
plates
Macular
schisis*
Peripheral
schisis**
1/50 His626Arg exon 6
residue 209
0.34 19/21 OD +
2/39 Trp96Arg exon 4 0.40 / 0.20 21/21 OU
3/32 Trp96Arg exon 4 0.80 / 0.88 21/21 OU + +
4/24 Arg141His exon 5 0.58 / 0.42 21/21 OU + + (OD only)
5/20 Deletion of splicing
acceptor site
IVS4del ttCtcgg
1.30 / 0.90 9/21-19/21 + + (OD only)
6/15 Large deletion in
exon 1
0.38 / 0.28 21/21 OU +
7/38 Gly70 Ser exon 4 0.52 / 0.48 20/21-21/21 +
8/14 G to T at nucleotide
88 in exon 3 lead to
premature stop
codon
0.36 / 0.40 21/21 OU +
9/32 Gly70Ser exon 4 0.70 / 0.64 21/21 OU + +
10/12 Arg141His exon 5 0.30 / 0.88 20/21-7/21 +
11/10 Arg141His exon 5 0.44 / 0.26 21/21 OU +
12/15 Arg3ins1cG exon 1 0.10 / 0.76 4/21 OU +
13/12 Arg3ins1cG exon 1 0.40 / 0.40 21/21 OU + + (OD only)
14/27 20bp insertion exon
4 codon 74
0.30 / 0.30 18/21 OU
*

Diagnosed by OCT and fundus exam

**

Diagnosed by Indirect Ophthalmoscopy

‘+’, presence; ‘-’, absence